Evidence map›Paper›PMID 29997296›Full record

ArticleJCI insight2018

Circulating RIPK3 levels are associated with mortality and organ failure during critical illness.

Kevin C Ma, Edward J Schenck, Ilias I Siempos, Suzanne M Cloonan, Eli J Finkelsztein, Maria A Pabon, Clara Oromendia, Karla V Ballman, Rebecca M Baron, Laura E Fredenburgh and 9 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in JCI insight, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04169412 (Resuscitation Failure, Protein Carbonyl and Receptor Interacting Protein Kinase 3 as Mortality Predictor in Septic Patient), which is not on this map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04169412 completednot on this mapstarted 2019, after this paper: background citation

Resuscitation Failure, Protein Carbonyl and Receptor Interacting Protein Kinase 3 as Mortality Predictor in Septic Patient

Typeobservational_patient_registrySponsorUniversitas SriwijayaRan2019 to 2019Enrolled72ConditionsSepsisArmsBlood Collection
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 46 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Acute lung injury: a view from the perspective of necroptosis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 2 countries.

Kevin C MaDivision of Pulmonary and Critical Care Medicine, Joan and Sanford I. Weill Department of Medicine.
Edward J SchenckDivision of Pulmonary and Critical Care Medicine, Joan and Sanford I. Weill Department of Medicine.
Ilias I SiemposDivision of Pulmonary and Critical Care Medicine, Joan and Sanford I. Weill Department of Medicine.
Suzanne M CloonanDivision of Pulmonary and Critical Care Medicine, Joan and Sanford I. Weill Department of Medicine.
Eli J FinkelszteinDivision of Pulmonary and Critical Care Medicine, Joan and Sanford I. Weill Department of Medicine.
Maria A PabonDivision of Pulmonary and Critical Care Medicine, Joan and Sanford I. Weill Department of Medicine.
Clara OromendiaDepartment of Healthcare Policy and Research, Division of Biostatistics and Epidemiology, Weill Cornell Medicine, New York, New York, USA.
Karla V BallmanDepartment of Healthcare Policy and Research, Division of Biostatistics and Epidemiology, Weill Cornell Medicine, New York, New York, USA.
Rebecca M BaronDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School. Boston, Massachusetts, USA.
Laura E FredenburghDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School. Boston, Massachusetts, USA.
Angelica HigueraDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School. Boston, Massachusetts, USA.
Jin Young LeeDepartment of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Chi Ryang ChungDepartment of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kyeongman JeonDepartment of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Jeong Hoon YangDepartment of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Judie A HowrylakDivision of Pulmonary, Allergy, and Critical Care Medicine, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.
Jin-Won HuhDepartment of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Gee Young SuhDepartment of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Augustine Mk ChoiDivision of Pulmonary and Critical Care Medicine, Joan and Sanford I. Weill Department of Medicine.
Samsung Medical Center · KRBrigham and Women's Hospital · USNewYork–Presbyterian Hospital · USPulmonary and Critical Care Associates · USCornell University · USPenn State Milton S. Hershey Medical Center · USUlsan College · KR

Funding

Disparities in COVID Disease Severity and Outcomes in New York CityUL1TR002384 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI JULIANNE L IMPERATO-MCGINLEY · 2017 to 2026
$86.2M
Respiratory Computational Discovery CoreP01HL114501 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CHOI, MARY E · 2013 to 2025
$24.9M
Mesenchymal Stromal Cell Conditioning by Carbon MonoxideP01HL108801 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI CHOI, AUGUSTINE M · 2011 to 2015
$13.8M
Institutional Career Development CoreKL2TR002385 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI YUAN-SHAN ZHU · 2017 to 2026
$13.3M
The Role of HEME Oxygenase in Hyperoxic Lung InjuryR01HL055330 · NHLBI · YALE UNIVERSITY · PI CHOI, AUGUSTINE M, CHOI, MARY E · 1998 to 2021
$6.6M
HEME OXYGENASE 1--LUNG VASCULAR CELL HYPOXIC RESPONSER01HL060234 · NHLBI · YALE UNIVERSITY · PI CHOI, AUGUSTINE M, CHOI, MARY E · 1999 to 2017
$5.8M
Heme oxygenase-1: Regulation and Function in CaveolaeR01HL079904 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CHOI, MARY E · 2005 to 2014
$2.9M
Clinical and Translational Science CenterKL2TR000458 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI IMPERATO-MCGINLEY, JULIANNE L · 2012 to 2016
$2.1M
Mitochondrial Iron metabolism in Chronic Obstructive Pulmonary DiseaseK99HL125899 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CLOONAN, SUZANNE M · 2015 to 2016
$285k
NCATS NIH HHS KL2 TR000458NCATS NIH HHS KL2 TR002385NCATS NIH HHS UL1 TR002384NHLBI NIH HHS K99 HL125899NHLBI NIH HHS P01 HL108801NHLBI NIH HHS P01 HL114501NHLBI NIH HHS R01 HL055330NHLBI NIH HHS R01 HL060234NHLBI NIH HHS R01 HL079904
6 · The paper itself

Abstract

backgroundNecroptosis is a form of programmed necrotic cell death that is rapidly emerging as an important pathophysiological pathway in numerous disease states. Necroptosis is dependent on receptor-interacting protein kinase 3 (RIPK3), a protein shown to play an important role in experimental models of critical illness. However, there is limited clinical evidence regarding the role of extracellular RIPK3 in human critical illness.

methodsPlasma RIPK3 levels were measured in 953 patients prospectively enrolled in 5 ongoing intensive care unit (ICU) cohorts in both the USA and Korea. RIPK3 concentrations among groups were compared using prospectively collected phenotypic and outcomes data.

resultsIn all 5 cohorts, extracellular RIPK3 levels in the plasma were higher in patients who died in the hospital compared with those who survived to discharge. In a combined analysis, increasing RIPK3 levels were associated with elevated odds of in-hospital mortality (odds ratio [OR] 1.7 for each log10-unit increase in RIPK3 level, P < 0.0001). When adjusted for baseline severity of illness, the OR for in-hospital mortality remained statistically significant (OR 1.33, P = 0.007). Higher RIPK3 levels were also associated with more severe organ failure.

conclusionsOur findings suggest that elevated levels of RIPK3 in the plasma of patients admitted to the ICU are associated with in-hospital mortality and organ failure.

fundingSupported by NIH grants P01 HL108801, R01 HL079904, R01 HL055330, R01 HL060234, K99 HL125899, and KL2TR000458-10. Supported by Samsung Medical Center grant SMX1161431.

Indexed as

AgedApoptosisCritical IllnessFemaleHospital MortalityHumansIntensive Care UnitsLogistic ModelsMaleMiddle AgedMultiple Organ FailureMultivariate AnalysisNecrosisOdds RatioReceptor-Interacting Protein Serine-Threonine KinasesRepublic of KoreaReceptor-Interacting Protein Serine-Threonine KinasesRIPK3 protein, humanApoptosis survival pathwaysInflammationInnate immunity

Identifiers

PMID29997296
PMCPMC6124535
OpenAlexW2814347658

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.